Skip to content
lifestyle.recentlegalnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Santhera Pharmaceuticals Holding AG
Santhera’s Licensing Partner, Nxera Pharma, Submits Marketing Authorization Application for AGAMREE® (Vamorolone) in South Korea
October 23, 2026
Santhera Pharmaceuticals Half Year Results for the six months ending 30 June 2026
September 30, 2026
Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting
May 26, 2026
Santhera Publishes Agenda for its Annual General Meeting
May 5, 2026
Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors
April 30, 2026
Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025
April 28, 2026
Santhera Announces Positive AIFA Board Decision on Reimbursement of AGAMREE® (vamorolone) in Italy
April 28, 2026
Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU
April 27, 2026
Santhera Appoints Stifel as Corporate Finance Advisor
February 11, 2026